Phase II study of a novel taxane (Cabazitaxel-XRP 6258) in previously treated advanced non-small cell lung cancer (NSCLC) patients.
about
Phase II study of a novel taxane (Cabazitaxel-XRP 6258) in previously treated advanced non-small cell lung cancer (NSCLC) patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Phase II study of a novel taxa ...... lung cancer (NSCLC) patients.
@en
Phase II study of a novel taxane
@nl
type
label
Phase II study of a novel taxa ...... lung cancer (NSCLC) patients.
@en
Phase II study of a novel taxane
@nl
prefLabel
Phase II study of a novel taxa ...... lung cancer (NSCLC) patients.
@en
Phase II study of a novel taxane
@nl
P2093
P2860
P1476
Phase II study of a novel taxa ...... lung cancer (NSCLC) patients.
@en
P2093
Ankit Madan
Benjamin S Jones
Bradford E Jackson
Deborah K Miley
Francisco Robert
Mansoor N Saleh
Mary S Jerome
Rodolfo Bordoni
P2860
P2888
P304
P356
10.1007/S00280-016-3088-5
P577
2016-07-14T00:00:00Z